Major pharmaceutical companies are actively integrating Artificial Intelligence (AI) across various stages, from drug discovery and development to clinical trials. Among them, AstraZeneca has distinguished itself by deploying AI-powered clinical trial technology on an unprecedented public health scale.
While competitors primarily focus on optimizing internal research and development pipelines, AstraZeneca's AI is already embedded within national healthcare systems. This technology has screened hundreds of thousands of patients, demonstrating the real-world impact of AI in addressing public health challenges.